{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:04:56Z","timestamp":1787508296055,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR6806\/GBD\/27\/480\/2012"],"award-info":[{"award-number":["BT\/PR6806\/GBD\/27\/480\/2012"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.lfs.2017.11.016","type":"journal-article","created":{"date-parts":[[2017,11,12]],"date-time":"2017-11-12T08:17:54Z","timestamp":1510474674000},"page":"238-245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Melatonin protects against behavioral deficits, dopamine loss and oxidative stress in homocysteine model of Parkinson's disease"],"prefix":"10.1016","volume":"192","author":[{"given":"Rajib","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banashree Chetia","family":"Phukan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arokiasamy","family":"Justin Thenmozhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thamilarasan","family":"Manivasagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallab","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6283-5367","authenticated-orcid":false,"given":"Anupom","family":"Borah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2017.11.016_bb0005","doi-asserted-by":"crossref","first-page":"42026","DOI":"10.1074\/jbc.M508628200","article-title":"Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication","volume":"280","author":"Panov","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2017.11.016_bb0010","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.freeradbiomed.2013.01.018","article-title":"Parkinson disease: from pathology to molecular disease mechanisms","volume":"62","author":"Dexter","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2017.11.016_bb0015","first-page":"107","article-title":"Homocysteine and Parkinson's disease: a complex relationship","volume":"1","author":"Doherty","year":"2013","journal-title":"J. Neurol. Disord."},{"key":"10.1016\/j.lfs.2017.11.016_bb0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.lfs.2015.07.031","article-title":"The potential physiological crosstalk and interrelationship between two sovereign endogenous amines, melatonin and homocysteine","volume":"139","author":"Paul","year":"2015","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.lfs.2017.11.016_bb0025","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.bbagen.2016.06.018","article-title":"l-DOPA-induced hyperhomocysteinemia in Parkinson's disease: elephant in the room","volume":"1860","author":"Paul","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.lfs.2017.11.016_bb0030","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/092986710790149774","article-title":"Elevated homocysteine levels in Parkinson's disease: is there anything besides l-DOPA treatment?","volume":"17","author":"Zoccolella","year":"2010","journal-title":"Curr. Med. Chem."},{"issue":"11","key":"10.1016\/j.lfs.2017.11.016_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050496","article-title":"Elevated homocysteine by levodopa is detrimental to neurogenesis in parkinsonian model","volume":"7","author":"Shin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2017.11.016_bb0040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neulet.2016.06.011","article-title":"l-DOPA treatment in MPTP-mouse model of Parkinson's disease potentiates homocysteine accumulation in substantia nigra","volume":"628","author":"Bhattacharjee","year":"2016","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.lfs.2017.11.016_bb0045","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.neuro.2005.01.008","article-title":"Effects of homocysteine on the dopaminergic system and behavior in rodents","volume":"26","author":"Lee","year":"2005","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.lfs.2017.11.016_bb0050","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainres.2005.12.073","article-title":"Acute intranigral homocysteine administration produces stereotypic behavioral changes and striatal dopamine depletion in Sprague-Dawley rats","volume":"1075","author":"Chandra","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.lfs.2017.11.016_bb0055","first-page":"47","article-title":"Chronic exposure of homocysteine in mice contributes to dopamine loss by enhancing oxidative stress in nigrostriatum and produces behavioral phenotypes of Parkinson's disease","volume":"6","author":"Bhattacharjee","year":"2016","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.lfs.2017.11.016_bb0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuint.2016.10.001","article-title":"Oxidative stress and mitochondrial dysfunction are the underlying events of dopaminergic neurodegeneration in homocysteine rat model of Parkinson's disease","volume":"101","author":"Bhattacharjee","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.lfs.2017.11.016_bb0065","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.brainres.2010.05.010","article-title":"Salicylic acid protects against chronic l-DOPA-induced 6-OHDA generation in experimental model of Parkinsonism","volume":"1344","author":"Borah","year":"2010","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.lfs.2017.11.016_bb0070","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.mehy.2012.05.008","article-title":"l-DOPA induced-endogenous 6-hydroxydopamine is the cause of aggravated dopaminergic neurodegeneration in Parkinson's disease patients","volume":"79","author":"Borah","year":"2012","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.lfs.2017.11.016_bb0075","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.tips.2009.06.005","article-title":"Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?","volume":"30","author":"Cicchetti","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2017.11.016_bb0080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-pharmtox-011613-135937","article-title":"Environmental toxins and Parkinson's disease","volume":"54","author":"Goldman","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.lfs.2017.11.016_bb0085","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1600-079X.2007.00465.x","article-title":"Melatonin inhibits oxidative stress and apoptosis in fetal brains of hyperhomocysteinemic rat dams","volume":"43","author":"Baydas","year":"2007","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2017.11.016_bb0090","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.pbb.2010.06.009","article-title":"Neuroprotective effects of the polyphenolic antioxidant agent, curcumin, against homocysteine-induced cognitive impairment and oxidative stress in the rat","volume":"96","author":"Ataie","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.lfs.2017.11.016_bb0095","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11011-011-9232-3","article-title":"Homocysteine alters glutamate uptake and Na+, K+-ATPase activity and oxidative status in rats hippocampus: protection by vitamin C","volume":"26","author":"Machado","year":"2011","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"10.1016\/j.lfs.2017.11.016_bb0100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/138161212798918995","article-title":"Curcumin: a potential neuroprotective agent in Parkinson's disease","volume":"18","author":"Mythri","year":"2012","journal-title":"Curr. Pharm. Des."},{"issue":"8","key":"10.1016\/j.lfs.2017.11.016_bb0105","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.bbadis.2013.09.007","article-title":"Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes","volume":"1842","author":"Jin","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2017.11.016_bb0110","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF03033256","article-title":"Melatonin fails to protect against long-term MPTP-induced dopamine depletion in mouse striatum","volume":"1","author":"van der Schyf","year":"2000","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.lfs.2017.11.016_bb0115","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/jnr.22201","article-title":"Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model","volume":"88","author":"Tapias","year":"2010","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.lfs.2017.11.016_bb0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1600-079X.2003.00096.x","article-title":"Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum","volume":"36","author":"Thomas","year":"2004","journal-title":"J. Pineal Res."},{"issue":"3","key":"10.1016\/j.lfs.2017.11.016_bb0125","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-079X.2006.00412.x","article-title":"Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model","volume":"42","author":"Saravanan","year":"2007","journal-title":"J. Pineal Res."},{"issue":"4","key":"10.1016\/j.lfs.2017.11.016_bb0130","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1600-079X.2009.00713.x","article-title":"Melatonin inhibits 6-hydroxydopamine production in the brain to protect against experimental Parkinsonism in rodents","volume":"47","author":"Borah","year":"2009","journal-title":"J. Pineal Res."},{"issue":"3","key":"10.1016\/j.lfs.2017.11.016_bb0135","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/jpi.12212","article-title":"Melatonin enhances l-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice","volume":"58","author":"Naskar","year":"2015","journal-title":"J. Pineal Res."},{"issue":"Suppl. 3","key":"10.1016\/j.lfs.2017.11.016_bb0140","first-page":"183","article-title":"Melatonin influences antioxidant homeostasis and basal metabolism in the BALB\/c mouse model","volume":"33","author":"Pohanka","year":"2012","journal-title":"Neuro Endocrinol. Lett."},{"issue":"4","key":"10.1016\/j.lfs.2017.11.016_bb0145","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/jpi.12267","article-title":"Melatonin: an ancient molecule that makes oxygen metabolically tolerable","volume":"59","author":"Manchester","year":"2015","journal-title":"J. Pineal Res."},{"issue":"1","key":"10.1016\/j.lfs.2017.11.016_bb0150","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1096\/fj.00-0129com","article-title":"Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity","volume":"15","author":"Dabbeni-Sala","year":"2001","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.lfs.2017.11.016_bb0155","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12640-012-9337-4","article-title":"Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes","volume":"23","author":"Pandi-Perumal","year":"2013","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.lfs.2017.11.016_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1994.tb56817.x","article-title":"Melatonin as a free radical scavenger: implications for aging and age-related diseases","volume":"719","author":"Reiter","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2017.11.016_bb0165","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1034\/j.1600-079x.2002.10824.x","article-title":"Homocysteine levels are increased due to lack of melatonin in pinealectomized rats: is there a link between melatonin and homocysteine?","volume":"32","author":"Baydas","year":"2002","journal-title":"J. Pineal Res."},{"issue":"4","key":"10.1016\/j.lfs.2017.11.016_bb0170","first-page":"717","article-title":"Melatonin decreases homocysteine level in blood of rats","volume":"59","author":"Murawska-Cialowicz","year":"2008","journal-title":"J. Physiol. Pharmacol."},{"issue":"7","key":"10.1016\/j.lfs.2017.11.016_bb0175","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3109\/13880209.2014.957782","article-title":"Beneficial effects of melatonin on serum nitric oxide, homocysteine, and ADMA levels in fructose-fed rats","volume":"53","author":"Kantar","year":"2015","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.lfs.2017.11.016_bb0180","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2013"},{"issue":"2","key":"10.1016\/j.lfs.2017.11.016_bb0185","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.pbb.2006.05.017","article-title":"Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine","volume":"84","author":"Sindhu","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.lfs.2017.11.016_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171285","article-title":"Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: involvement of mitochondrial dysfunctions and oxidative stress","volume":"12","author":"Paul","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2017.11.016_bb0195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neuint.2017.01.021","article-title":"Hypercholesterolemia causes psychomotor abnormalities in mice and alterations in cortico-striatal biogenic amine neurotransmitters: relevance to Parkinson's disease","volume":"108","author":"Paul","year":"2017","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.lfs.2017.11.016_bb0200","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuint.2005.12.016","article-title":"l-Deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats","volume":"49","author":"Saravanan","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.lfs.2017.11.016_bb0205","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0955-2863(99)00033-9","article-title":"A new HPLC method for the simultaneous determination of oxidized and reduced plasma aminothiols using coulometric electrochemical detection","volume":"10","author":"Melnyk","year":"1999","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.lfs.2017.11.016_bb0210","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","article-title":"Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase","volume":"47","author":"Marklund","year":"1974","journal-title":"Eur. J. Biochem."},{"issue":"18","key":"10.1016\/j.lfs.2017.11.016_bb0215","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1097\/00001756-199812210-00022","article-title":"Melatonin increases striatal dopaminergic function in 6-OHDA-lesioned rats","volume":"9","author":"Joo","year":"1998","journal-title":"Neuroreport"},{"issue":"4\u20135","key":"10.1016\/j.lfs.2017.11.016_bb0220","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.lfs.2013.01.007","article-title":"Increased melatonin may play dual roles in the striata of a 6-hydroxydopamine model of Parkinson's disease","volume":"92","author":"Lin","year":"2013","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.lfs.2017.11.016_bb0225","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0006-8993(02)02551-9","article-title":"Protective effect of melatonin in a chronic experimental model of Parkinson's disease","volume":"943","author":"Antol\u00edn","year":"2002","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.lfs.2017.11.016_bb0230","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-079X.2009.00721.x","article-title":"Visualization of melatonin's multiple mitochondrial levels of protection against mitochondrial Ca(2+)-mediated permeability transition and beyond in rat brain astrocytes","volume":"48","author":"Jou","year":"2010","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2017.11.016_bb0235","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.brainres.2005.10.084","article-title":"Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease","volume":"1068","author":"Sharma","year":"2006","journal-title":"Brain Res."},{"issue":"12","key":"10.1016\/j.lfs.2017.11.016_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122124","article-title":"Melatonin: a mitochondrial targeting molecule involving mitochondrial protection and dynamics","volume":"17","author":"Tan","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2017.11.016_bb0245","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson's disease","volume":"106\u2013107","author":"Subramaniam","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.lfs.2017.11.016_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1600-079X.2003.00092.x","article-title":"Regulation of antioxidant enzymes: a significant role for melatonin","volume":"36","author":"Rodriguez","year":"2004","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2017.11.016_bb0255","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1179\/135100009X392548","article-title":"24-Hour variation in gene expression of redox pathway enzymes in rat hypothalamus: effect of melatonin treatment","volume":"14","author":"Jimenez-Ortega","year":"2009","journal-title":"Redox Rep."},{"key":"10.1016\/j.lfs.2017.11.016_bb0260","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-079X.2004.00180.x","article-title":"Inhibition of 5-aminolevulinic acid-induced DNA damage by melatonin, N1-acetyl-N2-formyl-5-methoxykynuramine, quercetin or resveratrol","volume":"38","author":"Onuki","year":"2005","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2017.11.016_bb0265","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1600-079X.2007.00518.x","article-title":"Cardiovascular diseases: protective effects of melatonin","volume":"44","author":"Tengattini","year":"2008","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2017.11.016_bb0270","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1139\/o00-018","article-title":"Effect of pineal indoles on activities of the antioxidant defense enzymes superoxide dismutase, catalase, and glutathione reductase, and levels of reduced and oxidized glutathione in rat tissues","volume":"78","author":"Liu","year":"2000","journal-title":"Biochem. Cell Biol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320517305933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320517305933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:14:23Z","timestamp":1758399263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320517305933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":54,"alternative-id":["S0024320517305933"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2017.11.016","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melatonin protects against behavioral deficits, dopamine loss and oxidative stress in homocysteine model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2017.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}